Navigation Links
ImaginAb, Inc. and GE Imanet Sign Agreement to Provide Customized, Targeted PET Imaging Agents for Drug Research
Date:10/11/2010

et's capabilities and ImaginAb's rapidly growing pharmaceutical industry clientele."

About ImaginAb

Founded in 2007 by UCLA Faculty (Dr. Rob Reiter and Dr. Anna Wu), ImaginAb, Inc. is a biotechnology company specializing in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications. The company has a significant pipeline of clinical products in development oriented towards unmet needs in cancer and immunology. ImaginAb is also developing a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT and optical imaging systems, and partners on a selective basis with biopharmaceutical companies with an interest in developing companion imaging agents for therapeutic antibody products.  For more information about ImaginAb, visit www.imaginab.com.

About GE Imanet

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.  The company's broad expertise in medical imaging and information technologies, medical diagnostics, drug discovery and performance solutions services help its customers to deliver better care to more people around the world at a lower cost.  Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE).  Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professional and their patients in more than 100 countries.  An integral part of GE Healthcare's Medical Diagnostics business, Imanet™ is a network of clinical PET centers conducting exploratory phase PET imaging studies to aid in the development of products for the pharmaceutical industry since 2001.  For more information about GE Healthcare, visit www.gehealthcare.com and 

SOURCE ImaginAb, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA)
2. Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of Euro 24.75 per Ordinary Share of Crucell
3. IGEN AMENDS DISTRIBUTION AGREEMENT AND ANNOUNCES FIRST SPECTRUM BUILD-OUT
4. Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement
5. Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement
6. NeoStem Presented at NASDAQ MarketSite in New York to Discuss Entry Into Merger Agreement With Progenitor Cell Therapy
7. GeneLink Announces HelixLife Private Label Distribution Agreement
8. TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication
9. Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses
10. Drug Development in Arizona Gets Boost Following ASU-Quintiles Agreement
11. Dynamic Ventures Corporation enters into a long-term agreement that brings $50 million annual sales opportunity for wholly owned subsidiary EZ-Build.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 Research and Markets has ... Market 2014-2018" report to their offering. ... synthetic biology covers the designing and engineering of completely ... the redesigning of natural biological systems that provide improved ... form of extreme genetic engineering because it not only ...
(Date:7/28/2014)... , July 28, 2014  David Hardison, Ph.D., ... by Deloitte , has been elected chairman of ... Consortium, a non-profit working to establish common protocols ... as it relates to electronic health records. ... mission of collaborating with organizations across the research ...
(Date:7/28/2014)... MO (PRWEB) July 28, 2014 ... and services that bring the power of genomics to ... inaugural Appistry Pipeline Challenge . , Two ... president of the National Center for Genome Resources, and ... Hospitals and Clinics of Kansas City. Rounding out the ...
(Date:7/28/2014)...  InterMune, Inc. (NASDAQ: ITMN ) today ... financial results at the close of the U.S. markets ... webcast will be hosted by InterMune at 4:30 p.m. ... and others may participate in the conference call by ... replay of the webcast and teleconference will be available ...
Breaking Biology Technology:Global Synthetic Biology Market 2014-2018 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2InterMune to Release Second Quarter Financial Results on August 6 2
... SANTA ANA, Calif. , July 21 Irvine Scientific announced ... in women,s health, located in Neuilly en Thelle, France. Effective ... embryo transfer catheters, oocyte retrieval needles, and intra-uterine insemination cannulas ... Prodimed has a long history of developing superior products ...
... Mich., July 21 Neogen Corporation (Nasdaq: NEOG ) ... year, which ended May 31, and a continuation of the company,s ... Neogen,s revenues for FY 2009 were $118,721,000, up from $102,418,000 ... in currency exchange rates that had an unfavorable impact of $2.7 ...
... JERUSALEM, Israel, July 21 Oramed,Pharmaceuticals, ... alternative drug delivery systems, today reported positive results from ... on type 1 diabetic,patients. The completion of this study ... Diabetes Mellitus, whereas, all Oramed,s trials up to,date have ...
Cached Biology Technology:Neogen Reports 16% Increase in Revenues 2Neogen Reports 16% Increase in Revenues 3Neogen Reports 16% Increase in Revenues 4Neogen Reports 16% Increase in Revenues 5Neogen Reports 16% Increase in Revenues 6Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 2
(Date:7/28/2014)... body,s natural virus killers to prevent and treat HIV ... strong inflammatory response these molecules can arouse as they ... by scientists at the Weizmann Institute and the National ... activity of these molecules interferons around the ... course of the disease. Their research appeared in ...
(Date:7/28/2014)... Biologically Inspired Engineering at Harvard University today announced ... by a newly formed private company to accelerate ... products. The announcement follows a worldwide ... (OTD) and the start-up Emulate Inc., relating to ... platform. , "This is a big win ...
(Date:7/28/2014)... the first man to reach the South Pole in ... international team of scientists led by Joe McConnell of ... pollution from industrial activities arrived long before. , Using ... locations around the Antarctic continent, including the South Pole, ... to date of lead pollution over the Earth,s southernmost ...
Breaking Biology News(10 mins):Interfering with interferon 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 3
... Changes in how genes in the immune system function ... cause of visual impairment in older adults, based on ... investigators. "Our findings are epigenetic in nature, ... expression has been modified, likely by environmental factors, in ...
... , A peer-reviewed study of the largest number of flame ... levels of at least one flame retardant that exceeded a ... will publish the study online on November 28, 12:01am ... Institute tested for 49 flame retardant chemicals in household dust, ...
... Tension is the theme running through the new ... international working group on stem cell research and ... and scientific norms of free exchange, but also ... interests, and privatized vs. nationalized health care systems. ...
Cached Biology News:NIH study suggests immune system could play a central role in AMD 2NIH study suggests immune system could play a central role in AMD 3New study: Many flame retardants in house dust -- unsafe levels 2New study: Many flame retardants in house dust -- unsafe levels 3East Asia faces unique challenges, opportunities for stem cell innovation 2East Asia faces unique challenges, opportunities for stem cell innovation 3